feed,title,long_url,short_url
Benzinga,Global Blood Therapeutics Q1 Earnings Miss Estimates On Disappointing Sales For Its Sickle-Cell Disease Drug,https://benzinga.com/general/biotech/21/05/20994871/global-blood-therapeutics-q1-earnings-miss-estimates-on-disappointing-sales-for-its-sickle-cell-d,https://j.mp/2SAN3BX
